Introduction {#Sec1}
============

In Cystic Fibrosis (CF) patients, pulmonary infections lead to a progressive decline in lung function \[[@CR1]\]. Although spirometry and, particularly, the forced expiratory volume at 1st second (FEV~1~) is considered a valuable measure for lung function monitoring \[[@CR2]\], variables derived from exercise testing, such as the cardio-pulmonary exercise test (CPET), are more sensitive than spirometry in detecting early structural pulmonary changes in CF patients \[[@CR3]\].

In adolescents with CF, an exaggerated ventilatory response to exercise but adequate to V'~CO2~ (normal V'~E~/V'~CO2\ slope~) was documented \[[@CR4]\] and, interestingly, in adult CF patients the V'~E~/V'~CO2~ at peak of exercise was an independent determinant of exercise limitation, especially in those with a worse lung function \[[@CR5]\]. Moreover, in adults with CF, a high prevalence of exercise dynamic hyperinflation (DH) was found, secondary to the development of air trapping during exercise; DH was also shown to be associated to poor resting lung function, reduced exercise tolerance and increased exertional dyspnea \[[@CR6]\].

High-resolution computed tomography (HRCT) of the lung is able to demonstrate a broad range of pulmonary abnormalities in CF patients with mild-to-moderate lung disease \[[@CR7]\], identifying lower airway inflammation and early lung impairments \[[@CR8]\]. The Brody score \[[@CR7]\] is a composite HRCT score including different radiological features of lung disease (Bronchiectasis-B, Airways Wall Thickening-AWT, Mucous plugging-MP, Parenchyma-P and Air Trapping-AT) and demonstrating a high inter-observer reproducibility \[[@CR9]\]. In CF patients, higher Brody scores indicate more severe disease \[[@CR7]\]; they are also strongly associated with lung disease progression \[[@CR10]\], predicting the rate of pulmonary exacerbations up to 10-year follow-up \[[@CR11]\].

Interestingly, with regards to the relationship between HRCT-derived variables and the ventilatory response to exercise, the emphysema HRCT metrics were independent predictors of exercise-induced DH and V'~E~/V'~CO2\ slope~ in COPD patients \[[@CR12]\]. In CF adults, however, no studies assessed the value of the variables derived from HRCT to determine both the exercise ventilatory response to CO~2~ and DH. Therefore, we aimed to identify in a large cohort of adult patients with CF the determinants of exercise ventilatory response to CO~2~ and DH using HRCT-derived metrics, as expressed by the Brody II score.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

We conducted this prospective study at the University Hospital of Parma (Italy) between June 2013 and July 2017. The main inclusion criteria were a confirmed diagnosis of CF as recommended by international guidelines \[[@CR13]\], age \> 18 years and a stable respiratory condition (i.e. patients free from exacerbations) for at least 4 weeks before enrolment Patients with lung transplant, pregnancy and concomitant malignancies or comorbidities (i.e. heart failure, previous rib fracture) which could preclude their safety were excluded.

The study was conducted according to the Declaration of Helsinki; all the procedures and their risks were explained to the patients, who gave their written informed consent for the participation to the study. The ethical committee of the University Hospital of Parma approved the protocol (approval number: 200084; 07 June 2013). All participants' data were anonymously analyzed and reported. No extramural funding was used to support the study.

Measurements {#Sec4}
------------

For all patients, anthropometric characteristics (age, gender, body mass index-BMI and fat-free mass index-FFMI), presence of diabetes, CFTR mutations (F508del/F508del, F508del/Other, or Other/Other), *Pseudomonas aeruginosa* colonization, long-term oxygen therapy and domiciliary non-invasive mechanical ventilation were recorded at the enrolment. BMI was calculated in kilograms per square meter. Body composition was also assessed by a foot-to-foot bioelectrical impedance analysis (BIA) method by a body composition analyzer (model SC-331S, Tanita, Tokyo, Japan). The fat-free mass (FFM) was standardized for height to calculate the FFM index (FFMI = FFM/height squared, in kilograms per square meter).

All lung function tests were performed according to the international recommendations \[[@CR14]\]. A flow-sensing spirometer and a body plethysmograph connected to a computer for data analysis (Vmax 22 and 6200, Sensor Medics, Yorba Linda, USA) were used for the measurements. FEV~1~ and forced vital capacity (FVC) were recorded; the FEV~1~/FVC ratio was considered as the index of airflow obstruction. Thoracic gas volume (TGV) was measured by body plethysmography with the patients painting against a closed shutter at a frequency slightly \< 1 Hz and supporting their cheeks with their hands. Total lung capacity (TLC) was obtained as the sum of TGV and related inspiratory capacity (IC). To ensure reproducibility for each spirometry and lung volume variables at least three measurements were taken; the highest value was considered. The flow-sensor was calibrated before each test using a three-liter syringe. FEV~1~, FVC, and IC were expressed as a percentage of the predicted values \[[@CR15]\].

Incremental CPET was performed according to the standardized international procedure \[[@CR16]\]. Patients were not pre-treated with β~2~ agonists before testing, but they could take their current therapies. After calibrating the oxygen and carbon dioxide analysers and flow mass sensor, patients were invited to sit on an electromagnetically braked cycle ergometer (Corival PB, Lobe Bv, Groningen, The Netherlands) and the saddle was adjusted properly to avoid the maximal extension of the knee. The exercise protocol involved an initial rest of 3 min, followed by unloaded cycling for another 3 min with an increment of 5 to 15 watts every minute, according to the patient's anthropometry and degree of functional impairment, in order to achieve an exercise time between 8 and 12 min. Patients were invited to maintain a pedalling frequency of 60 rates per minute.

Breath-by-breath oxygen uptake (V'~O2~ in L/min), carbon dioxide production (V'~CO2~ in L/min), tidal volume (V~T~ in L) and minute ventilation (V'~E~ in L/min) were recorded during the test (CPX/D; Med Graphics, St Paul, MN, USA). Patients were continuously monitored with a 12-lead electrocardiogram (Welch Allyn CardioPerfect, Delft, the Netherlands) and a pulse oximeter (Pulse Oximeter 8600, Nonin Medical Inc., MPLS, Mn U.S.A.). Blood pressure was measured every two minutes. Stopping criteria consisted of symptoms, such as unsustainable dyspnea, leg fatigue or chest pain, a significant ST-segment depression at ECG, or a drop in systolic blood pressure or oxygen saturation ≤ 84% \[[@CR17]\].

Workload and V'~O2\ at\ peak~ were recorded as the mean value of watts and V'~O2~ during the last 20 s of the test. V'~O2~ at peak was expressed as mL/kg/min. The ventilatory response during exercise was expressed as a linear regression function by plotting V'~E~ against V'~CO2~ obtained every 10 s, excluding data above the ventilatory compensation point \[[@CR17]\]. Then, the slope and Y intercept values were obtained from the V'~E~/V'~CO2~ regression line. V'~E~/V'~CO2~ at rest~,~ V'~E~/V'~CO2\ slope~ and V'~E~/V'~CO2\ intercept~ (L∙min^− 1^) were recorded. Values of V'~E~/V'~CO2\ slope~ ≥ 30 and \< 30, derived from the median value in our cohort, were used to define patients with an exercise ventilatory inefficiency (V*in*) and patients with ventilatory efficiency (V*ef*), respectively \[[@CR18]\].

The end-tidal pressure of CO~2~ (P~ETCO2~, in mm Hg) was measured as the mean of P~ETCO2~ during the 3-min rest period and during the last 20 s of the test; moreover, the difference between P~ETCO2~ at peak and P~ETCO2~ at rest (Δ P~ETCO2~) was recorded.

Changes in operational lung volumes were assessed every two minutes during exercise and at peak exercise, taking the IC measured at rest, as the baseline. After a full explanation of the procedure, satisfactory technique and reproducibility of IC maneuvers were established during an initial practice session at rest. Assuming that TLC remains constant during exercise \[[@CR19]\], a change in IC (Δ IC, L) ≤ − 0.100 L at peak of exercise was considered to define patients with DH, as reported from the literature \[[@CR20]\].

The cardiovascular response to exercise was expressed by the following parameters: oxygen pulse (O~2~ pulse), HR ~recovery~ and double product (DP) reserve. O~2~ pulse (in mL/beats/min) was calculated by dividing instantaneous V~O2~ by the HR and was recorded at rest and as the change between the peak of exercise and the resting phase (Δ O~2~ pulse) \[[@CR17]\]. HR ~recovery~ (in beats) was defined as the reduction of the HR at the peak exercise level compared to the HR after one minute of the exercise cessation \[[@CR17]\]. DP (mmHg\*bpm) at rest and at maximal exercise was calculated by the product of systolic blood pressure and HR \[[@CR21]\]; DP reserve was calculated as DP at maximal exercise minus DP at rest and was also expressed as a ratio to workload in watts.

Oxygen saturation (SpO~2~) was reported at rest and as the difference between values at peak of exercise and at rest (Δ SpO~2~). Peak dyspnea and fatigue were described as visual analogic scale (VAS) with 0--100 score and then divided by peak workload (watts) for analysis.

Patients were scanned with a 128-slice Somatom Definition Flash scanner (Siemens Medical Solutions, Forchheim, Germany). Technical parameters were as follows: volumetric acquisition, collimation 128 × 2 × 0.6 mm; 1 mm slice thickness, rotation time 0.28 msec; tube voltage 80--100 kVp; tube current modulation (CareDose) on. Images were visually scored using a window setting (− 1550 W, − 600 L). Each HRCT scan was evaluated independently by two radiologists (S.L. and P.P.), both with a 3-year imaging experience. Readers scored HRCTs using the Brody II scoring system \[[@CR7]\]. The total score (T) is the sum of the following sub-scores: Bronchiectasis-B, Airways Wall Thickening-AWT, Mucous Plugging-MP, Parenchyma-P (e.g. bullae, ground glass and consolidation) and Air Trapping-AT with decreased attenuation areas. Each of the five sub-scores is rated according to presence and severity, in each of the six lobes, lingula being considered as a separate lobe. All scores and sub-scores are expressed as a percentage of the maximum possible score, ranging from 0 (no pathological findings) to 100 (maximum severity).

Statistical analysis {#Sec5}
--------------------

Analyses were performed with IBM SPSS Statistics 25.0 (Armonk, New York, USA) and Shapiro-Wilk test was used to assess the normality of distribution. Data were reported as medians (1st quartile; 3rd quartile) for continuous variables with non-normal distribution or means ± standard deviation (SD) for those with normal distribution. Number of patients (%) was used for categorical variables. Comparison analysis were performed using the chi-square (*X*^2^) or the Fisher exact test for categorical variables and the *t* test or the nonparametric Mann-Whitney test for continuous variables. For multiple comparisons, the Bonferroni post-hoc analysis, the ANOVA, and the nonparametric Kruskal-Wallis test were used.

The interrater reliability was evaluated by a two-way random-effects model with mean of *k* raters and definition of consistency \[[@CR22]\]. The intraclass correlation coefficients (ICC) were interpreted by the following scale: ICC values \< 0.50 are indicative of "poor reliability", values between 0.50 and 0.75 indicate "moderate reliability", values between 0.75 and 0.90 indicate "good reliability", and values greater than 0.90 indicate "excellent reliability" \[[@CR23]\].

For correlation analysis, the Pearson or Spearman correlation coefficients were used for linear or normally distributed variables and for not linear or not normally distributed variables, respectively.

Receiver operating characteristic (ROC) curves were generated to calculate the area under the curve (AUC) with 95% confidence interval (CI) and to find the best cut-off with the related sensibility and specificity. Univariate and multivariate regression logistic models (method: Stepwise) were performed to predict the probability to have V*in* and DH (set as dependent variables). Odds ratios (OR) and 95% CI were calculated. A *p* value at two tails \< 0.05 was considered significant.

Results {#Sec6}
=======

Our study sample consisted of 52 adult patients with CF, normal-weight, with a wide range of lung function from normal to severe airflow obstruction and a normal-to-mildly reduced maximal exercise capacity. Variables related to spirometry and CPET demonstrated that, in comparison to patients with V*ef* and without DH and patients with V*in* and without DH, patients with V*in* and with DH had statistically significant lower values of FEV~1~% pred., FVC % pred., FEV~1~/FVC %, and lower values in V'~O2\ at\ peak~ ml/kg/min and workload in watts at peak without reaching statistical significance. Table [1](#Tab1){ref-type="table"} summarises the results about anthropometric and lung function characteristics and Table [2](#Tab2){ref-type="table"} CPET-related variables.Table 1General characteristics according to the ventilatory efficiency and dynamic hyperinflationVariablesStudy sample *n = 52*Patients with V*ef* and without DH *n = 10 (19%)*Patients with V*in* and without DH *n = 13 (25%)*Patients with V*ef* and with DH *n = 14 (27%)*Patients with V*in* and with DH *n = 15 (29%)p* value ^a^Age, years29.1 ± 8.130.9 ± 10.129.8 ± 826.3 ± 630 ± 8.70.494Male, %58804650600.373BMI, kg/m^2^21.4 \[19.5; 22.5\]22.3 \[21.7; 24.3\]20.8 \[19; 22.8\]20.9 \[19.8; 21.9\]20.9 \[18.8; 23.3\]0.230FFMI, kg/m^2^17.1 \[15.4; 18\]17.6 \[15.7; 18.3\]16.4 \[14.5; 17.4\]17 \[15.6; 18.2\]17.4 \[15.3; 18\]0.402Diabetes, %31502329270.523CFTR mutations, %0.972F508del/F508del4240393654F508del/Other4140464333Other/Other1720152113*Pseudomonas aeruginosa* colonization, %9480921001000.133LTOT, %80014130.328Domiciliary NIMV, %400770.647FEV~1~, % pred.69.2 ± 22.385.2 ± 22.382.1 ± 2061.7 ± 17.4 ^b\ c^54.3 ± 15.6 ^b\ c^**\< 0.001**FVC, % pred.89.6 ± 18.398.6 ± 17.1100.4 ± 2086 ± 12.877.5 ± 14.1 ^b\ c^**0.001**FEV~1~/FVC, %64.8 ± 12.272.8 ± 9.170.1 ± 11.859.9 ± 11.1 ^b^59.6 ± 11.3 ^b^**0.005**IC at rest, % pred.77.5 \[61.5; 91.7\]76.5 \[69.2; 104.5\]76 \[57.5; 103\]78 \[63.7; 89.5\]81 \[57; 87\]0.977V~T~ at rest, L0.64 \[0.48; 0.84\]0.61 \[0.37; 0.71\]0.86 \[0.67; 0.95\] ^b^0.50 \[0.44; 0.81\] ^c^0.61 \[0.54; 0.71\] ^c^**0.015**RR at rest, breath/min17.5 \[13; 21.5\]18 \[16.6; 20.7\]13 \[11.8; 18\]17 \[11.7; 24\]20 \[15.9; 26\]0.510Ventilatory efficiency (V*ef*) and inefficiency (V*in*) were defined according to the V'~E~/V'~CO2\ slope~ \< 30 and V'~E~/V'~CO2\ slope~ ≥ 30, respectively. Patients without and with dynamic hyperinflation (DH) were defined according to the peak-to-rest change of IC (Δ IC, L) \> − 0.100 L and ≤ − 0.100 L.Data are shown as number of patients (%), means ± SD or medians \[1st quartile; 3rd quartile\], unless otherwise stated*Abbreviations: BMI* body mass index, *FFMI* fat-free mass index, *LTOT* long-term oxygen therapy, *NIMV* non-invasive mechanical ventilation, *FEV*~*1*~ forced expiratory volume at 1st second, *FVC* forced vital capacity, *IC* inspiratory capacity, *V*~*T*~ tidal volume, *RR* respiratory rate^a^*p*-value calculated between all groups; ^b^ *p*-value \< 0.05 versus patients with V*ef* and without DH; ^c^ *p*-value \< 0.05 versus patients with V*in* and without DHBoldface variables are statistically significantsTable 2CPET-related variablesVariablesStudy sample *n = 52*Patients with V*ef* and without DHPatients with V*in* and without DHPatients with V*ef* and with DHPatients with V*in* and with DH*p* value ^a^V'~O2\ at\ peak~, ml/kg/min28.1 ± 8.231.0 ± 7.725.8 ± 7.330.7 ± 9.225.7 ± 7.90.180Workload, watts121 \[97; 169\]168 \[121; 216.5\]109 \[98; 146.5\]127.5 \[94.5; 188\]102 \[88; 138\]0.067Δ IC, L− 0.19 \[− 0.43; 0.15\]0.24 \[− 0.05; 0.37\]0.16 \[0.08; 0.55\]−0.43 \[− 0.54; − 0.21\] ^c\ e^−0.38 \[− 0.43; − 0.26\] ^c\ e^**\< 0.001**Δ V~T~, L0.89 \[0.51; 1.33\]1.34 \[0.95; 1.61\]0.92 \[0.44; 1.24\]0.88 \[0.57; 1.19\] ^b^0.64 \[0.29; 0.89\] ^b^**0.039**RR at peak, breath/min37 \[32; 44\]34 \[32.1; 41.5\]31 \[28; 38.9\]38.8 \[31.7; 42.5\]44 \[36; 51\]0.073V'~E~/V'~CO2\ at\ rest~43.4 ± 5.939.8 ± 5.142.1 ± 5.043.4 ± 5.346.9 ± 6.2 ^b^**0.017**V'~E~/V'~CO2\ slope~29.3 ± 4.825.6 ± 1.933.0 ± 4.4 ^c^24.9 ± 2.7 ^e^32.5 ± 2.3 ^c\ g^**\< 0.001**V'~E~/V'~CO2\ intercept~, L∙min^− 1^3.28 \[1.95; 4.33\]3.3 \[2.5; 3.6\]0.8 \[0.2; 2.6\] ^b^4 \[3.2; 7.4\] ^b\ d^3.6 \[2.6; 5\] ^d^**0.001**O~2~ pulse at rest, mL/beat/min3.2 \[2.3; 3.9\]3.3 \[2.1; 4.5\]3.3 \[2.1; 3.9\]3 \[2.5; 3.9\]3.3 \[2.3; 3.9\]0.948Δ O~2~ pulse, mL/beat/min7.0 ± 2.68.8 ± 2.76.0 ± 2.1 ^b^7.9 ± 3.05.9 ± 1.5 ^b^**0.008**Δ P~ETCO2~6 \[4; 9\]6.5 \[4.7; 8\]3 \[0.5; 6\]10 \[6.7; 14\] ^b\ e^6 \[3; 7\] ^f^**0.001**HR ~recovery~23 \[15.2; 28\]25 \[21.7; 31\]23 \[15.5; 27.5\]20.5 \[14.2; 24.5\]23 \[13; 29\]0.261HR/V~O2~56 \[46; 65.7\]47.5 \[41.7; 59\]59 \[47.5; 74\]50 \[42; 64.2\]62 \[52; 73\]0.122DP reserve15,251.1 ± 4192.615,387.0 ± 5090.414,966.5 ± 3391.415,063.2 ± 4187.215,582.7 ± 4582.20.980DP reserve/Workload123.8 ± 35.897.1 ± 36.1129.9 ± 36.3117.4 ± 27.9142.3 ± 31.9 ^b^**0.011**SpO~2~ at rest, %96.7 ± 1.797.3 ± 1.997.5 ± 1.396.4 ± 1.895.9 ± 1.70.079Δ SpO~2~, %−2.0 ± 3.3−0.6 ± 2.5−1.1 ± 2.7−3.9 ± 3.8− 2.0 ± 3.40.065Peak dyspnea0.51 \[0.39; 0.77\]0.43 \[0.25; 0.62\]0.55 \[0.44; 0.73\]0.52 \[0.36; 0.88\]0.57 \[0.45; 0.95\]0.384Peak fatigue0.65 \[0.45; 0.82\]0.47 \[0.38; 0.77\]0.74 \[0.60; 0.88\]0.60 \[0.34; 0.77\]0.71 \[0.57; 0.91\]0.198Data are shown as number of patients (%), means ± SD or medians \[1st quartile; 3rd quartile\], unless otherwise statedVariables with Δ were calculated as peak-to-rest changes*Abbreviations: V'*~*O2*~ oxygen uptake, *IC* inspiratory capacity, *V*~*T*~ tidal volume, *RR* respiratory rate, *V'*~*E*~ minute ventilation, *V'*~*CO2*~ carbon dioxide output, *P*~*ETCO2*~ end-tidal pressure of CO~2~, *HR* heart rate, *DP* double product, *SpO*~*2*~ oxygen saturationPeak dyspnea and peak fatigue were described as visual analogic scale (VAS) with 0--100 score and peak workload ratio^a^*p*-value calculated between all groups^b^*p*-value \< 0.05 versus patients with V*ef* and without DH^c^*p*-value \< 0.001 versus patients with V*ef* and without DH^d^*p*-value \< 0.05 versus patients with V*in* and without DH^e^*p*-value \< 0.001 versus patients with V*in* and without DH^f^*p*-value \< 0.05 versus patients with V*ef* and with DH^g^*p*-value \< 0.001 versus patients with V*ef* and with DHBoldface variables are statistically significants

The interrater reliability between the two radiologists was "excellent" for T (ICC 0.95; 95% CI 0.91 to 0.97), B (ICC 0.93; 95% CI 0.88 to 0.96), MP (ICC 0.93; 95% CI 0.88 to 0.96), and P (ICC 0.91; 95% CI 0.84 to 0.95), while was "good" for AWT (ICC 0.86; 95% CI 0.75 to 0.92) and AT (ICC 0.81; 95% CI 0.66 to 0.88). Then, the average value of each Brody II score was considered for all analyses. Examples of HRCT metrics according to the Brody II score are provided in Fig. [1](#Fig1){ref-type="fig"}, while in Fig. [2](#Fig2){ref-type="fig"} are illustrated for all patients the HRCT variables related to the Brody II scores. Among V*in* patients (Fig. [3](#Fig3){ref-type="fig"}, *bottom left*), only AT differed significantly compared to those with V*ef*. Patients with DH, in comparison to those without DH (Fig. [3](#Fig3){ref-type="fig"}, *bottom right*), had higher values of T, B, AWT, and MP, respectively. Patients with V*in* and with DH had higher values of T, B and AT compared to other groups (Fig. [3](#Fig3){ref-type="fig"}, *top*).Fig. 1Example of HRCT metrics according to the Brody II scoring system. *Abbreviations:* BLD indicates bronchial lumen diameter; AOD, adjacent pulmonary artery outer diameter; BWT, bronchial wall thickeningFig. 2Boxplots of HRCT variables in study sample. *Abbreviations:* T indicates total score; B, bronchiectasis score; AWT, airways wall thickening score; MP, mucous plugging score; P, parenchyma score; AT, air trapping scoreFig. 3Boxplots of HRCT variables according to the presence of associated ventilatory efficiency/inefficiency and/or presence or absence of dynamic hyperinflation (*(top),* ventilatory efficiency/inefficiency only *(bottom left)*, and presence/absence of dynamic hyperinflation only *(bottom right)*. *Abbreviations:* V*ef* and V*in* indicates ventilator efficiency and inefficiency, respectively; DH, dynamic hyperinflation; T, total score; B, bronchiectasis score; AWT, airways wall thickening score; MP, mucous plugging score; P, parenchyma score; AT, air trapping score. ^a^ *p* value calculated between groups; ^b^ *p* \< 0.05 versus patients with V*ef* and without DH; ^c^ *p* \< 0.05 versus patients with V*in* and without DH; ^d^ *p* value \< 0.05 versus patients with V*ef* and with DH

Significant correlations were found between V'~E~/V'~CO2\ intercept~ and V'~E~/V'~CO2\ slope~ and between V'~E~/V'~CO2\ intercept~ and Δ IC. No correlation, however, was found between V'~E~/V'~CO2\ slope~ and Δ IC (Fig. [4](#Fig4){ref-type="fig"})*.* Multiple comparisons between patient subgroups (Fig. [5](#Fig5){ref-type="fig"}) showed that V'~E~/V'~CO2\ intercept~ was significantly higher among patients with V*ef* and with DH compared to those with V*ef* and without DH and those with V*in* and without DH. Moreover, V'~E~/V'~CO2\ intercept~ was significantly lower in patients with V*in* and without DH than those with V*ef* and without DH and those with V*in* and with DH.Fig. 4Scatterplots between V'~E~/V'~CO2\ slope~, Δ IC and V'~E~/V'~CO2\ intercept~. Continuous and dash lines represent fit line and 95% CI, respectively. Vertical lines in the above scatterplots represent the defined cut-off of V'~E~/V'~CO2\ slope~ and Δ IC (30 and − 100 L, respectively)Fig. 5Boxplots of V'~E~/V'~CO2\ intercept~ according to the presence of associated ventilatory efficiency/inefficiency and/or presence or absence of dynamic hyperinflation. *Abbreviations:* V*ef* and V*in* indicates ventilator efficiency and inefficiency, respectively; DH, dynamic hyperinflation. ^a^ *p* \< 0.05

Regression analysis (Table [3](#Tab3){ref-type="table"}) showed that AT was the only independent predictor of V*in*, whilst T, B, AWT and MP were significant predictors of the development of DH.Table 3Receiver operating characteristic (ROC) variables and univariate regression predicting the probability to have exercise ventilatory inefficiency or dynamic hyperinflationVariablesROC variablesUnivariate regressionCut-offAUC95% CISensitivitySpecificityOR95% CI*p* valueDependent variable: Ventilatory inefficiency AT (score)7.90.6820.535 to 0.8290.7140.5833.501.10 to 11.09**0.033**Dependent variable: Dynamic hyperinflation T (score)53.60.7070.564 to 0.8490.7930.5654.981.47 to 16.86**0.010** B (score)16.10.6990.550 to 0.8480.7590.6084.881.48 to 16.12**0.009** AWT (score)13.00.6630.514 to 0.8110.7240.5653.411.07 to 10.87**0.038** MP (score)11.70.7110.570 to 0.8510.7930.5214.181.24 to 14.09**0.021***Abbreviations: AT* indicates air trapping score, *T* total score, *B* bronchiectasis score, *AWT* airways wall thickening score, *MP* mucous plugging scoreBoldface variables are statistically significants

Discussion {#Sec7}
==========

Our study in adult patients with CF allows us to highlight two main findings: *1)* there is no correlation between V*in* and DH and variables derived from spirometry and CPET seem to be complementary and specific to one condition rather another and *2)* Brody II scores at HRCT are able to discriminate and predict V*in* (AT) and DH (T, B, AWT and MP).

Ventilatory response to exercise in CF patients {#Sec8}
-----------------------------------------------

There are very few data about the ventilatory response to exercise in adult CF patients. In a retrospective study on 102 CF patients with mild-to-moderate lung disease, the authors reported that V~E~/V~CO2\ at\ peak~ was not related to airflow obstruction but to the V~O2\ at\ peak~ \[[@CR5]\]. High values of V~E~/V~CO2\ slope~ identify greater dead space (V~D~) due to more extensive emphysema and/or high pulmonary vascular pressures, poorer cardiac performance, higher sympathetic drive, worse exertional hypoxemia and greater ergoreceptor stimulation \[[@CR18]\]. Indeed, in a sample of CF children undergoing sub-maximal constant work rate exercise testing, the arterial partial pressure of carbon dioxide (PaCO~2~) levels were significantly related to alveolar ventilation rather than V~E~; this denotes the leading role of physiologic V~D~ in the quantitative determination of ventilatory response to exercise \[[@CR24]\].

In our cohort, data about the relationship between DH and lung function impairment at rest are in line with Stevens et al. \[[@CR6]\]. Surprisingly, we did not observe differences in term of exercise tolerance \[[@CR6]\]; however, patients with DH and V*in* had a tendency to show a poorer exercise tolerance (Table [2](#Tab2){ref-type="table"}). It is of note that in COPD patients, V~E~/V~CO2~ measurements may explain exercise intolerance, particularly in milder and in symptomatic patients with preserved FEV~1~ \[[@CR25]\], since an increased V~D~ may occur \[[@CR25]\].

The value of HRCT metrics in V*in* and DH {#Sec9}
-----------------------------------------

HRCT scores and CPET-variables have been often used separately to predict future outcomes in CF patients, such as early structural alterations \[[@CR3]\] or disease progression \[[@CR10], [@CR11]\]. However, in adult CF patients no studies looked for determinants of two exercise-induced functional scenario (presence of V*in* and DH) using HRCT scores.

Air trapping at HCRT is an important marker of distal airways disease in children with CF \[[@CR26]\] and in COPD patients \[[@CR27]\]. Using a modified Bhalla scoring system, a retrospective study \[[@CR28]\] demonstrated that HRCT abnormalities were more sensible than lung function (evaluated only by FEV~1~) to detect disease decline of adult CF patients; notably, patients with air trapping and moderate-to-severely impaired lung function had more rapid rate of deterioration \[[@CR28]\]. Moreover, in children with CF, air trapping demonstrated a significant relationship with non-invasive measures of ventilation inhomogeneity, such as the lung clearance index (LCI) \[[@CR29]\]. These aspects are in line with our regression analysis, in which AT score independently increases the probability to have V*in* which, at least for COPD patients, may define a series of worse disease-related features \[[@CR18]\]. Similarly, HRCT metrics on emphysema measured by low attenuation areas (LAA%) - that conceptually may be seen as a surrogate of AT - were shown to significantly explain V~E~/V~CO2\ slope~ in COPD patients in a multivariate adjusted linear regression model \[[@CR12]\].

MP, secondary to the basic ion-transport defect of the disease, represents a recognized HRCT hallmark of disease \[[@CR30]\] and, together with perfusion abnormalities seems to play a relevant role in exacerbation \[[@CR31]\]. Based on our results, it may also have a potentially reversible role on DH.

The V'~E~/V'~CO2\ intercept~ in CF patients {#Sec10}
-------------------------------------------

The relationship between V'~E~ and V'~CO2~ - when V'~CO2~ is equal to zero - represents the V'~E~/V'~CO2\ intercept~ \[[@CR18]\]. In normal subjects, V'~E~/V'~CO2\ intercept~ is a small positive value (\< 3 L∙min^− 1^) \[[@CR32]\]. In COPD patients, V'~E~/V'~CO2\ intercept~ is related to greater DH \[[@CR18]\] and it is associated with exertional dyspnea \[[@CR18]\].

In our CF patients, V'~E~/V'~CO2\ intercept~ values lead us to some considerations. Among the whole study group, the median value was high (3.28) and, in particular, it was higher in patients with V*ef* (V'~E~/V'~CO2\ slope~ \< 30) and with DH. As shown for COPD patients \[[@CR18]\], a high V'~E~/V'~CO2\ intercept~ is a necessary compromise for the progressive mechanical respiratory constraints, increased V~D~ and reduced V'~E~/V'~CO2\ slope~. Notably, it is proved that V'~E~/V'~CO2\ intercept~ reflects some aspects about the V~D~ \[[@CR33]\]. The increased V~D~ and ventilation inhomogeneity \[[@CR29]\] in our CF patients may explain the increased value of V'~E~/V'~CO2\ intercept~ in DH patients. Then, in this context it is plausible that V'~E~/V'~CO2\ intercept~ correlates with both V'~E~/V'~CO2\ slope~ and Δ IC. Because each condition (V*in* and DH) influences, in different ways, the V'~E~/V'~CO2\ intercept~ (Table [2](#Tab2){ref-type="table"}), the level of this parameter does not increase if the two conditions coexist (Fig. [5](#Fig5){ref-type="fig"}).

Strength and limitations of the study {#Sec11}
-------------------------------------

Although our study has some important points of strength (originality because for the first time the exercise-induced ventilatory response was considered and the wide cohort of adult CF, in which all participant performed both HRCT and CPET) we need to report some limitations. First, our study concerns data collected in a single center in Italy, in adult CF with a wide range of lung function from normal to severe airflow obstruction and a relatively well-conserved maximal exercise capacity. The considerations derived from our analyses cannot be translated into patients with different functional and physical characteristics. Secondly, data about ATs have been collected only during the inspiration phase. Although in CF a pilot study demonstrated a very good agreement between HRCT scores from end-expiratory and end-inspiratory scans \[[@CR34]\], we cannot be sure that the execution of the end-expiratory phase scans could have changed our findings.

Conclusion {#Sec12}
==========

In summary, our prospective study performed in a cohort of adult patients with CF showed the values of HRCT metrics as determinants of V*in* (AT) and DH (T, B, AWT and MP). Moreover, we highlighted in CF patients the functional and clinical potential role of V*in* and DH. We believe that in the future these aspects should be considered when exercise tolerance is assessed, such as for COPD patients. The comprehensive scenario for CF patients could be more interesting.
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:   bronchial wall thickening

CF

:   cystic fibrosis
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:   confidence interval
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:   dynamic hyperinflation
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:   end-tidal pressure of CO~2~
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:   respiratory rate
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:   oxygen saturation
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:   carbon dioxide production

V~E~
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:   ventilatory efficiency
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